vertigo
VERTIGO

Vertigo is having a sensation of spinning of either the surrounding or within oneself but physical movement does not exist.

It may be secondary to different causes that may be determined by numerous factors eg timing and duration, aggravating conditions or associated symptoms.
Central vertigo originates from the central nervous system (brainstem or cerebellum). It is uncommon but more serious and should be ruled out immediately.
Peripheral vertigo originates from the labyrinth or vestibular nerve.

Vertigo Drug Information

Drug Information

Indication: Vertigo, tinnitus &/or progressive hearing loss associated w/ Meniere's disease & Meniere-like syndrom...

Indication: Prophylaxis of migraine w/ or w/o aura. Symptomatic treatment of vestibular vertigo, due to a diagnosed functi...

Indication: Maintenance therapy for symptoms of cerebrovascular origins, labyrinthine & peripheral-circulatory disorde...

Indication: Symptomatic treatment of nausea & vertigo due to Meniere's disease & other labyrinthine disturbances, ...

Indication: Symptomatic relief of allergy or hypersensitivity reactions eg, hay fever, urticaria, angioedema, rhinitis, co...

Indication: Cerebral circulatory insufficiency & its functional manifestation (memory loss, decrease in intellectual c...

Indication: Symptomatic treatment of nausea & vertigo due to Meniere's disease & other labyrinthine disturbances, ...

Indication: Prophylaxis of migraine, peripheral venous insufficiency, occlusive arterial diseases.

Indication: Migraine prophylaxis, peripheral venous insufficiency, occlusive arterial disease.

Indication: Traditionally used to improve blood circulation.

1  /  5
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.